PITUITARY-ADENOMAS, SOME DIAGNOSTIC AND THERAPEUTIC ASPECTS

被引：0
作者：
VANDERLELY, AJ
DEHERDER, WW
LAMBERTS, SWJ
机构：
来源：
PHARMACY WORLD & SCIENCE | 1994年 / 16卷 / 05期
关键词：
ADENOMA; ADVERSE EFFECTS; DIAGNOSIS; DOPAMINERGIC AGENTS; HORMONE ANTAGONISTS; KETOCONAZOLE; OCTREOTIDE; PITUITARY DISEASES;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The treatment of almost all types of pituitary adenomas has changed considerably in recent years. New types of drugs as well as improved application forms of older drug therapies are now becoming more and more available for everyday treatment of patients with these relatively rare diseases. For the most frequently occurring pituitary adenomas the drugs of first choice are described, as well as other available treatments, their indications and efficacies. Also the main side-effects are described.
引用
收藏
页码：201 / 207
页数：7
相关论文
共 86 条
[51]   GROWTH ENHANCEMENT OF TRANSGENIC MICE EXPRESSING HUMAN INSULIN-LIKE GROWTH FACTOR-I [J].
MATHEWS, LS ;
HAMMER, RE ;
BEHRINGER, RR ;
DERCOLE, AJ ;
BELL, GI ;
BRINSTER, RL ;
PALMITER, RD .
ENDOCRINOLOGY, 1988, 123 (06) :2827-2833
[52]   PROLACTIN-LOWERING EFFECT OF ACUTE AND ONCE WEEKLY REPETITIVE ORAL-ADMINISTRATION OF CABERGOLINE AT 2 DOSE LEVELS IN HYPERPROLACTINEMIC PATIENTS [J].
MATTEI, AM ;
FERRARI, C ;
BAROLDI, P ;
CAVIONI, V ;
PARACCHI, A ;
GALPAROLI, C ;
ROMANO, C ;
SPELLECCHIA, D ;
GEREVINI, G ;
CROSIGNANI, PG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 66 (01) :193-198
[53]  
MCCOMB DJ, 1983, ARCH PATHOL LAB MED, V107, P488
[54]   DOSE-RELATED PROLACTIN INHIBITORY EFFECT OF THE NEW LONG-ACTING DOPAMINE RECEPTOR AGONIST CABERGOLINE IN NORMAL CYCLING, PUERPERAL, AND HYPERPROLACTINEMIC WOMEN [J].
MELIS, GB ;
GAMBACCIANI, M ;
PAOLETTI, AM ;
BENEVENTI, F ;
MAIS, V ;
BAROLDI, P ;
FIORETTI, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 65 (03) :541-545
[55]   PETROSAL SINUS SAMPLING - TECHNIQUE AND RATIONALE [J].
MILLER, DL ;
DOPPMAN, JL .
RADIOLOGY, 1991, 178 (01) :37-47
[56]   BROMOCRIPTINE AS PRIMARY THERAPY FOR PROLACTIN-SECRETING MACROADENOMAS - RESULTS OF A PROSPECTIVE MULTICENTER STUDY [J].
MOLITCH, ME ;
ELTON, RL ;
BLACKWELL, RE ;
CALDWELL, B ;
CHANG, RJ ;
JAFFE, R ;
JOPLIN, G ;
ROBBINS, RJ ;
TYSON, J ;
THORNER, MO .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 60 (04) :698-705
[57]   KETOCONAZOLE AND PLASMA AND URINE STEROID-LEVELS IN CUSHINGS-DISEASE [J].
MORTIMER, RH ;
CANNELL, GR ;
THEW, CM ;
GALLIGAN, JP .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1991, 18 (08) :563-569
[58]   EFFECT OF CV 205-502 IN HYPERPROLACTINAEMIC PATIENTS INTOLERANT OF BROMOCRIPTINE [J].
NEWMAN, CB ;
HURLEY, AM ;
KLEINBERG, DL .
CLINICAL ENDOCRINOLOGY, 1989, 31 (04) :391-400
[59]   MEDICAL THERAPY OF GLYCOPROTEIN HORMONE SECRETING PITUITARY-TUMORS [J].
OPPENHEIM, DS ;
KLIBANSKI, A .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1989, 18 (02) :339-358
[60]   HIGH-RESOLUTION MR IMAGING OF PITUITARY MICROADENOMAS AT 1.5-T - EXPERIENCE WITH CUSHING DISEASE [J].
PECK, WW ;
DILLON, WP ;
NORMAN, D ;
NEWTON, TH ;
WILSON, CB .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1989, 152 (01) :145-151
123456789